The global bioprinting market is still in its infancy and is forecasted to grow from 208.1 million USD in 2018 to 1.4 billion USD in 2024, at an overall CAGR of 35.4%. The figures vary from one market analysis to another, so we have decided to publish the numbers as they appear in BCC Research, Report BIO176A from May 2019.
The growth in this market has been driven by technological advancements in 3D bioprinters and biomaterials, increasing the use of 3D bioprinting in the pharmaceutical and cosmetology industries, in addition to rising public and private funding to support bioprinting research. Biopixlar is positioned to target the research application segment which currently represents more than 97% of the addressable market.